Duloxetine Hcl Capsule, Delayed Release
Product Images NDC 80425-0014

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine Hcl (NDC 80425-0014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig 1 (Fig 1)

Fig 1 (Fig 1)
FDA Label Image

Fig 10 (Fig 10)

Fig 10 (Fig 10)
FDA Label Image

Fig 2 (Fig 2)

Fig 2 (Fig 2)
FDA Label Image

Fig 3 (Fig 3)

Fig 3 (Fig 3)
FDA Label Image

Fig 4 (Fig 4)

Fig 4 (Fig 4)
The text appears to show data regarding the percentage of patients who improved with Duloxetine compared to a placebo, based on a pain scale. The doses of Duloxetine are mentioned as 60 mg BID and 60 mg QD. A graph is also included to display the percentage of improvement in pain from the baseline, in increments of 10 up to 100.*
FDA Label Image

Fig 5 (Fig 5)

Fig 5 (Fig 5)
The text describes a graph showing the percentage of patients and their corresponding improvement levels in pain. The x-axis displays the percentage of improvement while the y-axis shows the percentage of patients. The graph features three lines that depict the placebo and two different dosages of duloxetine taken once or twice daily. The non-readable characters prevent further interpretation.*
FDA Label Image

Fig 6 (Fig 6)

Fig 6 (Fig 6)
This is a graph displaying the percentage of patients who reported improvement in pain from baseline after taking Duloxetine at various doses. The doses tested were 120 mg, 60 mg, and 20 mg, once daily. The graph also includes a placebo group for comparison. The x-axis shows the percentage of improvement in pain and the y-axis shows the percentage of patients.*
FDA Label Image

Fig 8 (Fig 8)

Fig 8 (Fig 8)
The figure in the text represents the "Percentage of Patients Improved" after taking Duloetine at a dose of 60/120 mg once compared to Placebo. The numbers along the bottom likely represent the baseline levels of pain (BOCF), while the numbers on the vertical axis indicate the percentage of patients that experience improvement in pain levels.*
FDA Label Image

Fig 9 (Fig 9)

Fig 9 (Fig 9)
This is a chart showing the percentage of patients improved with Placebo and Duloxetine, with Duloxetine being administered at 60mg once-daily. The chart shows a horizontal axis ranging from 0 to 290, with 10 points between each interval. The vertical axis shows a percentage improvement in pain from baseline (BOCF), ranging from 0 to 100.*
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Label 1 (Label 1)

Label 1 (Label 1)
FDA Label Image

Label 2 (Label 2)

Label 2 (Label 2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.